Provisional Consent to the Distribution of a New Medicine Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution inNew Zealand of the new medicine set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Interferon beta-lb 0.3 mg (9.6 million IU) and sodium chloride 0.54% w/v in 2 mL as diluent Powder for injection (vial) and diluent Chiron Corporation, Emeryville, California, United States of America and B Braun Medical SA, Los Olivares, Jaen, Spain (diluent only) Betaferon Note: This medicine may only be distributed, supplied, or used under conditions to be imposed from time to time by the Director-General of Health. Dated this 12th day of September 1995. KAREN O. POUTASI, Director-General of Health, pursuant to delegation given by the Minister of Health on 25 June 1993.